Chester County News and Community Website
PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a CD5-modulated autologous CAR-T therapy, at the upcoming American …
New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal Read More PHILADELPHIA, PA — Vittoria Biotherapeutics Inc. has announced its upcoming presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. The trials-in-progress poster will spotlight …
Vittoria Biotherapeutics to Present VIPER-101 Phase 1 Trial at 2025 ASCO Annual Meeting Read More PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a cutting-edge gene-edited cell therapy aimed at treating relapsed and refractory (r/r) T …
Vittoria Biotherapeutics Launches Trial for Innovative T Cell Lymphoma Therapy Read More PHILADELPHIA, PA — Vittoria Biotherapeutics announced a significant publication by University of Pennsylvania investigators in Science Immunology. The paper highlights the role of CD5, an immunomodulatory protein, in enhancing engineered …
Vittoria Biotherapeutics’ Senza5 Platform Featured in Science Immunology Read More